Seroprevalence and Cross-reactivity of Human Polyomavirus 9
Jérôme T.J. Nicol, Antoine Touzé, Rémy Robinot, Francoise Arnold, Elisa Mazzoni, Mauro Tognon, and Pierre Coursaget
Author affiliations: Institut National de la Santé et de la Recherche Médicale, Tours, France (J.T.J. Nicol, A. Touzé, R. Robinot, F. Arnold, P. Coursaget); Université François Rabelais, Tours (J.T.J. Nicol, A. Touzé, R. Robinot, F. Arnold, P. Coursaget); and School of Medicine, University of Ferrara, Ferrara, Italy (E. Mazzoni, M. Tognon)
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.